1870 related articles for article (PubMed ID: 14572558)
1. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
2. Features of gastroesophageal reflux disease in women.
Lin M; Gerson LB; Lascar R; Davila M; Triadafilopoulos G
Am J Gastroenterol; 2004 Aug; 99(8):1442-7. PubMed ID: 15307857
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
Tack J; Koek G; Demedts I; Sifrim D; Janssens J
Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial.
Johnson DA; Ganz R; Aisenberg J; Cohen LB; Devière J; Foley TR; Haber GB; Peters JH; Lehman GA
Am J Gastroenterol; 2003 Sep; 98(9):1921-30. PubMed ID: 14499767
[TBL] [Abstract][Full Text] [Related]
5. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
Watson TJ; Peters JH
Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
[TBL] [Abstract][Full Text] [Related]
6. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
7. The role of esophageal pH monitoring in symptomatic patients on PPI therapy.
Charbel S; Khandwala F; Vaezi MF
Am J Gastroenterol; 2005 Feb; 100(2):283-9. PubMed ID: 15667483
[TBL] [Abstract][Full Text] [Related]
8. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
[TBL] [Abstract][Full Text] [Related]
9. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
[TBL] [Abstract][Full Text] [Related]
10. Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia.
Conchillo JM; Selimah M; Bredenoord AJ; Samsom M; Smout AJ
Aliment Pharmacol Ther; 2007 Apr; 25(8):965-71. PubMed ID: 17403001
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
Eloubeidi MA; Provenzale D
Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
[TBL] [Abstract][Full Text] [Related]
12. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
13. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
Milkes D; Gerson LB; Triadafilopoulos G
Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].
Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A
Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369
[TBL] [Abstract][Full Text] [Related]
15. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
16. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?
Tefera L; Fein M; Ritter MP; Bremner CG; Crookes PF; Peters JH; Hagen JA; DeMeester TR
Am Surg; 1997 Oct; 63(10):933-6. PubMed ID: 9322676
[TBL] [Abstract][Full Text] [Related]
17. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux.
Oelschlager BK; Chang L; Pope CE; Pellegrini CA
J Surg Res; 2005 Sep; 128(1):55-60. PubMed ID: 16115493
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results.
Khajanchee YS; Hong D; Hansen PD; Swanström LL
Am J Surg; 2004 May; 187(5):599-603. PubMed ID: 15135673
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease in children: association between symptoms and pH monitoring.
Størdal K; Johannesdottir GB; Bentsen BS; Sandvik L
Scand J Gastroenterol; 2005 Jun; 40(6):636-40. PubMed ID: 16036522
[TBL] [Abstract][Full Text] [Related]
20. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
